Publications by authors named "Massimo Lopez"

Claim this Profile
C
Chemotherapy with or without low-dose interleukin-2 in advanced non-small cell lung cancer: results from a phase III randomized multicentric trial.
Laura Ridolfi, Oscar Bertetto, Antonio Santo, Emanuele Naglieri, Massimo Lopez

Int J Oncol· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cetuximab plus FOLFOX-4 in untreated patients with advanced colorectal cancer: a Gruppo Oncologico dell'Italia Meridionale Multicenter phase II study.
Giuseppe Colucci, Francesco Giuliani, Carlo Garufi, Rodolfo Mattioli, Luigi Manzione, Massimo Lopez

Oncology· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A multicenter prospective phase II randomized trial of epirubicin/vinorelbine versus pegylated liposomal doxorubicin/vinorelbine as first-line treatment in advanced breast cancer. A GOIM study.
Patrizia Vici, Giuseppe Colucci, Francesco Giotta, Domenico Sergi, Gianfranco Filippelli, Massimo Lopez

J Exp Clin Cancer Res· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I-II trial of prolonged gemcitabine infusion plus paclitaxel as a biweekly schedule for advanced breast cancer patients pretreated with anthracyclines.
Patrizia Vici, Alessandra Fabi, Giulio Metro, Domenico Sergi, Diana Giannarelli, Massimo Lopez

Cancer Chemother Pharmacol· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An unusual site of metastasis from gastrointestinal stromal tumor.
Carolina Cauchi, Jonathan C Trent, Kristin Edwards, Monica Davey, Massimo Lopez

Rare Tumors· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Laparoscopic resection of sporadic synchronous gastric and jejunal gastrointestinal stromal tumors: report of a case.
Roberto Dell'Avanzato, Fabio Carboni, Maria Beatrice Palmieri, Raffaele Palmirotta, Fiorella Guadagni, Massimo Lopez

Surg Today· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The antiretroviral nucleoside analogue Abacavir reduces cell growth and promotes differentiation of human medulloblastoma cells.
Alessandra Rossi, Giuseppe Russo, Andrew Puca, Raffaele La Montagna, Mariella Caputo, Massimo Lopez

Int J Cancer· July 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multicenter phase II trial of first-line docetaxel/gemcitabine in advanced breast cancer pretreated with adjuvant anthracyclines.
Patrizia Vici, Francesco Giotta, Luigi DI Lauro, Mario Brandi, Vittorio Gebbia, Massimo Lopez

Anticancer Res· May 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II study of epirubicin, oxaliplatin and docetaxel combination in metastatic gastric or gastroesophageal junction adenocarcinoma.
Luigi Di Lauro, Laura Giacinti, Maria Grazia Arena, Domenico Sergi, Silvia Ileana Fattoruso, Massimo Lopez

J Exp Clin Cancer Res· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase II trial of docetaxel and vinorelbine in patients with advanced breast cancer previously treated with anthracyclines.
Patrizia Vici, Luigi Di Lauro, Domenico Sergi, Paolo Foggi, Giuditta Viola, Massimo Lopez

Oncology· November 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oral vinorelbine and cisplatin as induction chemotherapy and concomitant chemo-radiotherapy in stage III non-small cell lung cancer: final results of an international phase II trial.
Maciej Krzakowski, Mariano Provencio, Beata Utracka-Hutka, Eugenio Villa, Manuel Codes, Massimo Lopez

J Thorac Oncol· September 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Paraneoplastic Raynaud phenomenon with digital necrosis associated with hyperhomocysteinemia and antiphospholipid antibodies.
Massimo Carducci, Roberta Calcaterra, Massimo Rinaldi, Anna Mussi, Giuditta Viola, Massimo Lopez

Arch Dermatol· October 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Myeloid toxicity in breast cancer patients receiving adjuvant chemotherapy: what is the appropriate use of filgrastim?
Gianluigi Ferretti, Massimo Lopez, Edmondo Terzoli, Enrico Cortesi, Mauro Antimi

J Clin Oncol· December 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical trials.
Laura Giacinti, Massimo Lopez, Antonio Giordano

Front Biosci· September 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Does granulocyte colony-stimulating factor worsen anemia in early breast cancer patients treated with epirubicin and cyclophosphamide?
Paola Papaldo, Gianluigi Ferretti, Serena Di Cosimo, Diana Giannarelli, Paolo Marolla, Massimo Lopez

J Clin Oncol· July 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sequential chemotherapy with cisplatin/gemcitabine (CG) followed by mitoxantrone/methotrexate/mitomycin (MMM) in patients with malignant pleural mesothelioma. A multicenter Italian Phase II Study (SITMP1).
Carmine Pinto, Antonella Marino, Vincenzo De Pangher Manzini, Giovanni Benedetti, Domenico Galetta, Massimo Lopez

Lung Cancer· May 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epigenetic information and estrogen receptor alpha expression in breast cancer.
Laura Giacinti, Pier Paolo Claudio, Massimo Lopez, Antonio Giordano

Oncologist· January 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of five prophylactic filgrastim schedules on hematologic toxicity in early breast cancer patients treated with epirubicin and cyclophosphamide.
Paola Papaldo, Massimo Lopez, Paolo Marolla, Enrico Cortesi, Mauro Antimi

J Clin Oncol· October 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pretreatment quality of life and functional status assessment significantly predict survival of elderly patients with advanced non-small-cell lung cancer receiving chemotherapy: a prognostic analysis of the multicenter Italian lung cancer in the elderly study.
Paolo Maione, Francesco Perrone, Ciro Gallo, Luigi Manzione, FrancoVito Piantedosi, Massimo Lopez

J Clin Oncol· October 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase III randomized trial of FOLFIRI versus FOLFOX4 in the treatment of advanced colorectal cancer: a multicenter study of the Gruppo Oncologico Dell'Italia Meridionale.
Giuseppe Colucci, Vittorio Gebbia, Giancarlo Paoletti, Francesco Giuliani, Michele Caruso, Massimo Lopez

J Clin Oncol· August 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Potentiation of the antitumoral activity of gemcitabine and paclitaxel in combination on human breast cancer cells.
Gabriella Zupi, Marco Scarsella, Carmen D'Angelo, Annamaria Biroccio, Giancarlo Paoletti, Massimo Lopez

Cancer Biol Ther· August 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sequential docetaxel followed by epirubicin-vinorelbine as first-line chemotherapy in advanced breast cancer.
Patrizia Vici, Paolo Foggi, Giuseppe Colucci, Elisabetta Capomolla, Mario Brandi, Massimo Lopez

Anticancer Res· May 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel association with gemcitabine and docetaxel as salvage chemotherapy in metastatic breast cancer previously treated with anthracyclines: results of a multicenter phase II study.
Mario Brandi, Patrizia Vici, Massimo Lopez, Maria Rosaria Valerio, F Giotta

Semin Oncol· April 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Addition of either lonidamine or granulocyte colony-stimulating factor does not improve survival in early breast cancer patients treated with high-dose epirubicin and cyclophosphamide.
Paola Papaldo, Massimo Lopez, Enrico Cortesi, Eugenio Cammilluzzi, Mauro Antimi

J Clin Oncol· September 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interleukin-2, interferon-alpha and medroxyprogesterone acetate in metastatic renal cell carcinoma.
Emanuele Naglieri, Massimo Lopez, Giorgio Lelli, Francesco Morelli, Antonella Amodio

Anticancer Res· February 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis